Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Artivion ( (AORT) ) has provided an update.
On September 12, 2025, Artivion, Inc. entered into a Second Amendment to its Credit and Guaranty Agreement, which involves extending the maturity date of its existing term loans and revolving credit facility by one year to January 18, 2031. The amendment also includes a reduction in the interest rate margin and introduces a new $150 million secured delayed draw term loan facility. This strategic financial move allows Artivion to prepay loans with a premium if done before July 18, 2027, and provides flexibility for funding acquisitions, investments, and capital expenditures, potentially strengthening its market position.
The most recent analyst rating on (AORT) stock is a Buy with a $50.00 price target. To see the full list of analyst forecasts on Artivion stock, see the AORT Stock Forecast page.
Spark’s Take on AORT Stock
According to Spark, TipRanks’ AI Analyst, AORT is a Neutral.
Artivion’s overall score is driven by strong earnings call results and positive corporate events, but is weighed down by financial performance challenges and lack of technical analysis data.
To see Spark’s full report on AORT stock, click here.
More about Artivion
Average Trading Volume: 440,801
Technical Sentiment Signal: Buy
Current Market Cap: $1.92B
For detailed information about AORT stock, go to TipRanks’ Stock Analysis page.